AIAA has submitted a bid to bring IAC 2029 to Houston, tying the event to the GRB South expansion and the city’s space legacy.

A Cleveland man whose heart stopped for 82 minutes recovered neurologically intact after UH Elyria used ECPR, spotlighting fast EMS-to-hospital coordination.

Mass General Brigham teams pair gene research with a validated Brain Care Score that studies link to sizable reductions in dementia risk.

Las Vegas investigators say ChatGPT queries were used in planning the Jan. 1, 2025 Cybertruck explosion — reviving debate over whether AI firms must warn police.

One year after CHOPs first personalized CRISPR case, hospital leaders want to scale the approach into a platform for other rare pediatric diseases. Early signs are promising but major hurdles remain.

The Tampa Bay Times is using a template-driven 'Times AI News Engine' to post short AI-written real-estate notices and weather alerts since September 2025. Editors say staff review most templates while a public AI policy is finalized.

A Texas State/X‑Bow plan to static‑test solid rocket motors at Freeman Ranch has neighbors and conservationists warning the Edwards Aquifer could be at risk. University officials say safeguards are planned.

Mount Sinai is rolling out face‑scan check‑ins with CLEAR1 across its hospitals and clinics, promising faster check‑ins and fewer duplicate records while prompting privacy debate.

Morehouse landed a $5M NSF share to build a campus site for Horizon, bringing leadership‑class AI and research compute to the Atlanta HBCU and partner schools.

Hong Kong’s RedotPay is reportedly weighing a New York IPO that could raise more than $1 billion and value the company north of $4 billion as regulators ready licenses. Investors will be watching reserves and redemption rules closely.

An Austin business court heard arguments this week over whether CrowdStrike is really headquartered here as GoSecure accuses the company of using stolen trade secrets. The judge took the matter under advisement.

A northwest Missouri fossil hunter recovered a 92‑pound bone he believes is a Columbian mammoth femur; CT scans and radiocarbon dating are planned to verify the claim.

Alveus Therapeutics extended its Series A to $197M and moved its U.S. headquarters to Philadelphia to accelerate development of its obesity drug programs.